Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer.
about
Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.CanVar: A resource for sharing germline variation in cancer patients.Findings in young adults at colonoscopy from a hospital service database auditGermline mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.Undefined familial colorectal cancer and the role of pleiotropism in cancer susceptibility genes.Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing.Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.MRE11 stability is regulated by CK2-dependent interaction with R2TP complex.How many cases of disease in a pedigree imply familial disease?Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.Expanding the spectrum of germline variants in cancer.The wide spectrum of POT1 gene variants correlates with multiple cancer types.Genome-wide association studies of cancer: current insights and future perspectives.Screening of BMPR1a for pathogenic mutations in familial colorectal cancer type X families from Newfoundland.NTHL1 and MUTYH polyposis syndromes: two sides of the same coin?Germline mutations in patients with multiple colorectal polyps in China.Inherited DNA-Repair Defects in Colorectal Cancer.Recent progress in Lynch syndrome and other familial colorectal cancer syndromes.Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.Germline Variants in the POT1-Gene in High-Risk Melanoma Patients in Austria.Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer familyKnockdown of POLE2 expression suppresses lung adenocarcinoma cell malignant phenotypes in vitro
P2860
Q30275554-83112C86-EA35-46E6-AB39-3226ECE56FC1Q30490732-7EA42C7B-2148-4AC9-B2B4-32916783DEE5Q33576415-77B4A474-AB6E-4AE0-AA97-5F80DB29B5AAQ36104721-68AD048A-98F4-4C14-80D9-BF22717DBDA6Q37231035-C3E4808A-BAD4-49F6-92C0-C0E3C8C9F1DCQ37710155-DB769F8F-F877-468D-98CB-959F23315474Q38974107-B7BE0E57-A0CA-4357-ABD0-B3F272E5E849Q41151587-B448F5C4-7A15-4F97-A4D4-C32BF1B8C613Q47312439-18CF7B7E-B74E-4974-B891-F80033EF4A51Q47321577-C2DFDAC1-2865-4A29-B265-438EC5D1F33FQ47567905-3044E740-97B8-4DE0-8799-E661E1103F6EQ47884482-07BF5B4E-32BF-42C2-8775-7203F954E2B5Q47900293-39EBA189-80F5-4362-BE27-63902060A9ECQ48204735-B1E61D82-064B-457D-94C6-E83B6EBABC92Q48363305-E889346A-9DF8-4E8F-9DE2-1C84D75C5289Q48818506-A3092257-0761-42F4-A7DE-3ADB1E7FCD88Q52686318-8A31BC59-9A68-430B-9747-C6CC69D66FD1Q53081522-79501056-AD99-4795-BDE8-21606D045610Q54116561-E753BF56-2E45-4BC4-8807-FE1A4E6E0FD3Q55395329-FBDB2EF3-814F-4AFF-985F-E858FB0CCFBEQ56350284-C41C8C38-DC70-4418-A92A-1E599031EB7AQ58767639-D9544B65-6895-4CC5-A4B8-00AD47F9038F
P2860
Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Rare disruptive mutations and ...... ble risk of colorectal cancer.
@ast
Rare disruptive mutations and ...... ble risk of colorectal cancer.
@en
Rare disruptive mutations and ...... ble risk of colorectal cancer.
@en-gb
type
label
Rare disruptive mutations and ...... ble risk of colorectal cancer.
@ast
Rare disruptive mutations and ...... ble risk of colorectal cancer.
@en
Rare disruptive mutations and ...... ble risk of colorectal cancer.
@en-gb
prefLabel
Rare disruptive mutations and ...... ble risk of colorectal cancer.
@ast
Rare disruptive mutations and ...... ble risk of colorectal cancer.
@en
Rare disruptive mutations and ...... ble risk of colorectal cancer.
@en-gb
P2093
P2860
P50
P953
P356
P1154
2-s2.0-84975743169
P1476
Rare disruptive mutations and ...... able risk of colorectal cancer
@en
P2093
Daniel Chubb
Ian Tomlinson
Matthew Frampton
Sara E Dobbins
Steven Penegar
Yussanne P Ma
P2860
P2888
P356
10.1038/NCOMMS11883
P407
P50
P5530
P577
2016-06-22T00:00:00Z
P6179
1005369769